Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law)—why? One of the ballooning costs are clinical trials. Pharma/biotech often outsource their trials to CROs (contract research organisations). But many CROs are incentivised to make trials as bloated and inefficient as possible. That means more money and less results. Meri Beckwith is building the anti-CRO: Lindus Health—to solve this problem. 0:00 Intro 1:39 The big problem in drug discovery 4:10 Why do CROs exist? 7:24 The incentive problem in drug discovery/CROs 10:57 Pharma are anti-startups 12:11 How much a clinical trial costs 15:11 How can you compete with big CROs? 17:26 Are you going to build your own drug pipeline? 18:56 Lessons from VC to Founder 23:42 Brand/PR/Positioning as a biotech startup 29:03 Billion dollar ideas in bio/health 31:33 Habits that have helped Meri Links Lindus Health: https://www.lindushealth.com/ Meri Beckwith: https://twitter.com/meribeckwith Mithi Thaya: https://www.linkedin.com/in/mithi-thaya/ Dr Mustafa Sultan: https://www.musty.io/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related